Search research articles
Contact Us
Filters
Showing results (91-100 of 115) with videos related to
Page
of 12
Sort By:
Experimental and Molecular Pathology
|
May 11, 2026
A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma
Stefano Scalera, Laura Cipriani, Andrea Scarinci, et al.
Frontiers in Oncology
|
July 13, 2023
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study
Agnese Fabbri, Fabrizio Nelli, Andrea Botticelli, et al.
Scientific Reports
|
September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
Laura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
Journal of Translational Medicine
|
February 7, 2018
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
Elisa Melucci, Beatrice Casini, Livia Ronchetti, et al.
Journal of Cellular Physiology
|
July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting
Teresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Cancers
|
August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Journal for Immunotherapy of Cancer
|
August 8, 2020
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
Marco Mazzotta, Marco Filetti, Mario Occhipinti, et al.
Journal of Cellular Physiology
|
November 19, 2016
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer
Teresa Gamucci, Lucia Mentuccia, Clara Natoli, et al.
Cancers
|
October 14, 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study
Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, et al.
Cancer Biology & Therapy
|
January 17, 2018
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab
Laura Pizzuti, Domenico Sergi, Isabella Sperduti, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 115) with videos related to
Sort By:
Page
of 12
Experimental and Molecular Pathology
|
May 11, 2026
A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma
Stefano Scalera, Laura Cipriani, Andrea Scarinci, et al.
Frontiers in Oncology
|
July 13, 2023
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study
Agnese Fabbri, Fabrizio Nelli, Andrea Botticelli, et al.
Scientific Reports
|
September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
Laura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
Journal of Translational Medicine
|
February 7, 2018
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
Elisa Melucci, Beatrice Casini, Livia Ronchetti, et al.
Journal of Cellular Physiology
|
July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting
Teresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Cancers
|
August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Journal for Immunotherapy of Cancer
|
August 8, 2020
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
Marco Mazzotta, Marco Filetti, Mario Occhipinti, et al.
Journal of Cellular Physiology
|
November 19, 2016
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer
Teresa Gamucci, Lucia Mentuccia, Clara Natoli, et al.
Cancers
|
October 14, 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study
Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, et al.
Cancer Biology & Therapy
|
January 17, 2018
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab
Laura Pizzuti, Domenico Sergi, Isabella Sperduti, et al.
Page
of 12